ARMISTICE CAPITAL, LLC purchased 0.6% of their position (288K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $231.6K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 2/22/2022ACC: 0000899243-22-007249
Director10% Owner
Since Jun 2018
+288K
Net shares
Net buyer
$231.6K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
288K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+150K
Price / share
$0.81
Trade value
$122.25K
% of position
0.3%
2/17/2022
46.41M→46.56M
Common Stock
Indirect
Shares
+55K
Price / share
$0.82
Trade value
$45.24K
% of position
0.1%
2/18/2022
46.56M→46.62M
Common Stock
Indirect
Shares
+83K
Price / share
$0.77
Trade value
$64.08K
% of position
0.2%
2/22/2022
46.62M→46.70M
Total
Net shares
+288K
Net value
$231.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/17/2022 | P · Purchase | +150K | $0.81 | $122.25K | 0.3% | 46.41M | 46.56M |
| Common Stock Indirect | 2/18/2022 | P · Purchase | +55K | $0.82 | $45.24K | 0.1% | 46.56M | 46.62M |
| Common Stock Indirect | 2/22/2022 | P · Purchase | +83K | $0.77 | $64.08K | 0.2% | 46.62M | 46.70M |
| Total | +288K | $231.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported